Supernus Pharmaceuticals ...

NASDAQ: SUPN · Real-Time Price · USD
31.87
0.17 (0.54%)
At close: Jun 02, 2025, 3:59 PM
31.91
0.13%
After-hours: Jun 02, 2025, 04:40 PM EDT

Supernus Pharmaceuticals Revenue Breakdown

Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
APOKYN Revenue 73.93M 75.08M 75.31M 99.23M 74.3M 88.19M 84.58M
APOKYN Revenue Growth -1.54% -0.29% -24.11% +33.56% -15.75% +4.27% n/a
GOCOVRI Revenue 130.82M 119.64M 104.42M 9.78M 98.72M 383.4M 399.87M
GOCOVRI Revenue Growth +9.35% +14.57% +967.92% -90.10% -74.25% -4.12% n/a
Manufactured Product, Other Revenue 29.01M 31.28M 31.82M 110.71M 509.35M 295.21M n/a
Manufactured Product, Other Revenue Growth -7.27% -1.69% -71.26% -78.26% +72.54% n/a n/a
Oxtellar X R Revenue 99.46M 113.4M 115.34M 567.5M 319.64M n/a n/a
Oxtellar X R Revenue Growth -12.29% -1.68% -79.68% +77.54% n/a n/a n/a
Product Revenue 637.7M 573.93M 649.43M 9.88M n/a n/a n/a
Product Revenue Growth +11.11% -11.63% +6473.86% n/a n/a n/a n/a
Qelbree Revenue 241.27M 140.19M 61.32M 304.82M n/a n/a n/a
Qelbree Revenue Growth +72.10% +128.62% -79.88% n/a n/a n/a n/a
Royalty, License And Other Revenue Revenue 24.12M 94.34M 261.22M n/a n/a n/a n/a
Royalty, License And Other Revenue Revenue Growth -74.43% -63.89% n/a n/a n/a n/a n/a
Trokendi Xr Revenue 63.2M n/a n/a n/a n/a n/a n/a
Trokendi Xr Revenue Growth n/a n/a n/a n/a n/a n/a n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 89.94M 79.41M 69.75M 85.9M 86.52M 81.28M 82.7M 86.78M 85.6M 73.97M 112.31M 100.48M 90.46M 101.73M 72.03M 69.53M 61.46M 56.5M 54.66M 48.1M 42.88M 35.73M 40.65M 41.08M 40.97M 42.05M 40.89M 40.1M 36.85M 33.76M 40.83M 35.08M 28.24M 29.05M 25.68M 26.12M 25.16M 23.57M 22.9M 23.34M 19.4M
Selling, General, and Administrative Revenue Growth +13.27% +13.84% -18.80% -0.71% +6.44% -1.71% -4.70% +1.38% +15.72% -34.14% +11.78% +11.07% -11.08% +41.24% +3.59% +13.14% +8.77% +3.37% +13.63% +12.19% +20.01% -12.11% -1.06% +0.28% -2.57% +2.83% +1.98% +8.81% +9.14% -17.30% +16.38% +24.22% -2.81% +13.16% -1.71% +3.82% +6.76% +2.91% -1.87% +20.28% n/a
Research and Development Revenue 26.93M 28.05M 29.04M 25.58M 24.32M 22.74M 22.66M 24.38M 21.21M 17.77M 19.55M 16.39M 20.84M 21.08M 19.65M 15.46M 34.28M 17.94M 16.84M 22.25M 18.94M 19.79M 16.94M 16.97M 15.39M 29.84M 20.42M 20.04M 18.91M 16.17M 12.98M 10.82M 9.6M 13.25M 7.87M 11.11M 10.56M 9.45M 9.13M 6.88M 3.68M
Research and Development Revenue Growth -3.99% -3.41% +13.50% +5.20% +6.94% +0.38% -7.07% +14.93% +19.34% -9.10% +19.34% -21.37% -1.13% +7.25% +27.17% -54.92% +91.10% +6.53% -24.31% +17.48% -4.32% +16.82% -0.16% +10.24% -48.41% +46.12% +1.92% +5.98% +16.91% +24.60% +19.93% +12.73% -27.55% +68.43% -29.17% +5.18% +11.81% +3.47% +32.73% +86.75% n/a
Sales and Marketing Revenue 63.28M 54.59M 54.33M 58.8M 59.57M 55.28M 56.78M 59.89M 57.23M 47.99M 85.7M 73.58M 60.51M 62.18M 50.7M 48.38M 38.45M 36.59M 39.17M 29.95M 29.04M 8.3M 29.58M 30.22M 30.75M 12.8M 11.6M 11.1M 7.9M 7.7M 9.6M 9.8M 6.7M 5.7M 4.9M 5M 6.4M 19.3M n/a n/a n/a
Sales and Marketing Revenue Growth +15.91% +0.49% -7.61% -1.28% +7.76% -2.66% -5.19% +4.65% +19.25% -44.00% +16.48% +21.60% -2.68% +22.63% +4.80% +25.84% +5.07% -6.59% +30.79% +3.13% +249.89% -71.94% -2.10% -1.72% +140.23% +10.34% +4.50% +40.51% +2.60% -19.79% -2.04% +46.27% +17.54% +16.33% -2.00% -21.88% -66.84% n/a n/a n/a n/a